A multicentre, randomized, double-blind, non-inferiority clinical trial to compare the clinical and radiological efficacy of 625 mg versus 1250 mg of oral methylprednisolone in patients with relapse of multiple sclerosis: Oral-CORTEM trial.

Ferran Torres, Jose-Vicente Hervas-Garcia, Silvia Presas-Rodriguez, Jaume Capellades, Gema Domenech, Sandra Serrano, Cristina Ramo-Tello

Research output: Contribution to journalArticleResearchpeer-review

Original languageEnglish
Number of pages2
JournalNeurology
Volume88
Issue numberSup. 16
Publication statusPublished - 18 Apr 2017

Cite this